We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$155M
AUM Growth
+$54M
(+53%)
Cap. Flow
+$50.3M
Cap. Flow
% of AUM
32.4%
Top 10 Holdings %
Top 10 Hldgs %
87.49%
Holding
34
New
12
Increased
6
Reduced
5
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$16M |
| 2 |
CELG
Celgene Corp
CELG
|
+$15M |
| 3 |
Fox Class A
FOXA
|
+$4.24M |
| 4 |
TSMC
TSM
|
+$4.19M |
| 5 |
AABA
Altaba Inc
AABA
|
+$3.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSU
Nevsun Resources Ltd.
NSU
|
+$10.7M |
| 2 |
EHIC
eHi Car Services Limited
EHIC
|
+$7.66M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
+$3.17M |
| 4 |
ORBK
Orbotech Ltd
ORBK
|
+$2.74M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 47.29% |
| 2 | Healthcare | 15.27% |
| 3 | Technology | 10.13% |
| 4 | Materials | 4.51% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFCF
1
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $46.8M | 30.15% |
979,026
| – | – |
|
|
RHT
2
DELISTED
Red Hat Inc
RHT
| $22.2M | 14.32% |
122,937
+89,465
| +267% | +$16M |
|
3
CALL
Bristol-Myers Squibb
BMY
$133B
| $18M | 11.6% |
+377,200
| New | +$18.8M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $16.2M | 10.44% |
+171,755
| New | +$15M |
|
|
5
TSMC
TSM
$2.1T
| $7.76M | 5% |
198,317
+109,767
| +124% | +$4.19M |
|
|
MLNX
6
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $6.59M | 4.25% |
+55,700
| New | +$5.6M |
|
7
BHP
BHP
$215B
| $6.39M | 4.12% |
130,960
+42,982
| +49% | +$1.96M |
|
|
IDTI
8
DELISTED
Integrated Device Technology I
IDTI
| $4.41M | 2.84% |
89,921
+46,609
| +108% | +$2.26M |
|
|
9
Fox Class A
FOXA
$24.5B
| $3.99M | 2.57% |
+108,777
| New | +$4.24M |
|
|
AABA
10
DELISTED
Altaba Inc
AABA
| $3.39M | 2.19% |
+45,763
| New | +$3.15M |
|
11
Takeda Pharmaceutical
TAK
$54.6B
| $2.79M | 1.8% |
+136,792
| New | +$2.75M |
|
|
CYOU
12
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $2.66M | 1.72% |
155,763
-22,500
| -13% | -$422K |
|
13
Moderna
MRNA
$21.8B
| $2.33M | 1.5% |
114,597
-17,171
| -13% | -$319K |
|
|
ATTU
14
DELISTED
Attunity Ltd
ATTU
| $2.23M | 1.44% |
+95,036
| New | +$2.12M |
|
15
Pacific Biosciences
PACB
$435M
| $1.5M | 0.97% |
205,623
+133,666
| +186% | +$967K |
|
|
ULTI
16
DELISTED
Ultimate Software Group Inc
ULTI
| $1.49M | 0.96% |
+4,501
| New | +$1.38M |
|
17
HSBC
HSBC
$365B
| $1.22M | 0.79% |
30,475
-761
| -2% | -$30.7K |
|
18
Korea Electric Power
KEP
$15.3B
| $1.21M | 0.78% |
92,885
+60,588
| +188% | +$904K |
|
|
NITE
19
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $865K | 0.56% |
+34,082
| New | +$603K |
|
|
CBPO
20
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $756K | 0.49% |
8,290
-2,900
| -26% | -$237K |
|
|
MLNX
21
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $658K | 0.42% |
+5,559
| New | +$559K |
|
22
POSCO
PKX
$16.1B
| $605K | 0.39% |
+10,951
| New | +$634K |
|
|
PTR
23
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $554K | 0.36% |
+8,473
| New | +$548K |
|
24
SK Telecom
SKM
$12.1B
| $367K | 0.24% |
8,319
| – | – |
|
|
GSUM
25
DELISTED
Gridsum Holding Inc.
GSUM
| $181K | 0.12% |
61,072
-11,584
| -16% | -$33.1K |
|
Similar funds
THCM
WG
FAL
AIA
DMC
KL
UOC
MFA
Athos Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Athos Capital held 34 positions worth $155M, up 53% from $101M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Athos Capital deployed $50.3M of net new capital in Q1 2019, opening 12 new positions and adding to 6 existing holdings. Its largest new stake was Celgene Corp: 171,755 shares worth $16.2M.
By sector, the portfolio is most concentrated in Communication Services at 47% of assets, down from 52% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Changyou.com Limited American Depositary Share, an estimated $422K trimmed.
- Athos Capital's largest Q1 2019 buy was Celgene Corp: 171,755 shares worth $16.2M.
- Athos Capital added most to Red Hat Inc in Q1 2019, an estimated $16M increase.
- Athos Capital's biggest Q1 2019 reduction was Changyou.com Limited American Depositary Share, cutting an estimated $422K.
- Athos Capital fully exited Nevsun Resources Ltd. in Q1 2019, selling an estimated $10.7M.
- Athos Capital's ten largest holdings make up 87% of its $155M portfolio in Q1 2019.
- Athos Capital opened 12 new positions and closed 9 in Q1 2019.
- Athos Capital's portfolio value rose 53% quarter-over-quarter to $155M.
Based on Athos Capital's 13F filing for Q1 2019, filed 14 May 2019.